deltatrials
Completed PHASE3 NCT00000379

Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)

Treatment of Outcomes of Fluoxetine vs EMDR in PTSD

Sponsor: Boston University

Conditions Stress Disorders, Post-Traumatic
Interventions EMDR Fluoxetine
Updated 5 times since 2017 Last updated: Feb 19, 2014 Started: Jan 31, 1999 Completion: Dec 31, 2003

A PHASE3 clinical study on Stress Disorders, Post-Traumatic, this trial is completed. The trial is conducted by Boston University and has accumulated 5 data snapshots since 1999. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jan 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston University
  • National Institute of Mental Health (NIMH)
Data source: Boston University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Brookline, United States